Breath is a patented wireless auscultation platform — a clinical-grade smart stethoscope, a multi-vital home device, and a shared AI cloud — that loops frontline workers and remote specialists into a single live exam.
Heart and lung sounds disappear the moment they're heard — nothing to compare, transmit, or act on.
The paramedic, nurse, ASHA worker or family member beside the patient usually isn't the one who can make the call.
Inconsistent decisions and missed early warnings — in emergencies, rural care, and chronic monitoring.
Auscultation: listening to internal body sounds (heart, lungs) — routinely used in physical exams to diagnose conditions and monitor vital functions.
A patented, scalable, cost-efficient framework that connects frontline point-of-care directly to remote medical networks.
Wireless Bluetooth chest-piece with digital amplification and active noise attenuation.
Every exam recorded, archived, and matched to patient history for trend tracking.
Low-latency streaming: a remote physician listens and diagnoses live.
Detects cardiac & pulmonary anomalies, gauges triage urgency, guides placement.
| Traditional auscultation | The Breath platform | |
|---|---|---|
| Audio | Acoustic tubing — faint, raw sounds | Digital amplification & noise isolation |
| Data | Isolated, never recorded | Continuous cloud archiving + AI baseline history |
| Reach | Physical, in-person only | Live multi-channel streaming (ambulance → specialist) |
| Design | Acoustic tube built into hardware | Wireless Bluetooth — patent granted in India |
Wireless chest-piece records high-fidelity heart & lung audio plus vitals.
Companion app forwards live audio + telemetry to the Breath cloud.
Edge & cloud AI flag anomalies, score triage urgency, guide placement.
Remote specialist listens live, reviews trends, and calls the next step.
Wireless, high-fidelity auscultation with live remote streaming. The frontline tool for doctors, hospitals, and ambulances.
A multi-vital hub for homes, chronic patients, and institutional monitoring — same cloud, same AI engine.
Every device feeds the same cloud record, AI engine, and mobile/tablet app.
India remote patient monitoring by 2033 (~22.5% CAGR). Global digital stethoscope export: $310M → $540M+ by 2034.
Indian PHCs & CHCs, district hospitals and medical colleges, plus ~22,000 ambulances and a GCC export channel.
Connected devices plus recurring RPM SaaS within a 3-year window.
~55–60% gross margin
~55% gross margin
Compounds with installed base
| 3M Littmann CORE | Eko CORE 500 | Thinklabs One | AyuSynk | Breath | |
|---|---|---|---|---|---|
| Price | ~₹24K+ | ₹32–70K | ~₹42K | ₹14.7–22K | ₹20–26K |
| Wireless streaming | Limited | Yes | No | Limited | Yes |
| Multi-vital (ECG + SpO₂) | No | 3-lead ECG | No | No | Yes (Life) |
| AI triage | Partial | Partial | No | No | Yes |
| India / GCC price-fit | No | No | No | Yes | Yes |
Sources: Littmann/3M, Eko, Thinklabs, AyuSynk — manufacturer list pricing.
The UAE is the natural launchpad for a connected medical platform serving the GCC and the wider emerging-market opportunity. We are setting up our export and software operations in Abu Dhabi to anchor regulatory, talent, and capital partnerships in one of the world's fastest-moving healthtech ecosystems.
Telemedicine and cloud EHR are now national infrastructure across the Gulf and India — not pilots.
Bluetooth audio + edge-AI components are now cheap enough to undercut the analog-premium price point.
Abu Dhabi's healthcare and innovation agenda explicitly backs scalable medical platforms with global ambition.
GCC export of Breath Core via a UAE entity from Year 2, unlocking higher-margin revenue and regional regulatory leverage.
Ambulance fleets, telehealth networks, and home-care providers across the Gulf are actively buying connected RPM today.
A founding team relocating operational gravity to Abu Dhabi — not a flag-of-convenience, an HQ.
Revenue scales from ₹7 Cr to ₹90 Cr over three years as institutional and RPM volume compound. GCC export via the UAE hub adds higher-margin revenue from Year 2; gross margin expands from 32% to 46%.
Early-year margins reflect sub-scale manufacturing and institutional/tender pricing; unit economics approach 55%+ at volume.
Basic wireless stethoscope = Class A, low-risk under India's Medical Device Rules 2017. Self-certification via Rule 19 with a Declaration of Conformity (CDSCO).
ECG/SpO₂ and anomaly-detection features qualify as Software as a Medical Device (Rule 3(zb)), pushing to Class B/C with clinical validation and a longer CDSCO review. CE / FDA are separate tracks.
Decades of medical-device entrepreneurship.
Sr. Product Designer at Google, NYC.
Sr. Product Manager at Google, Bay Area.
Sr. Product Designer at Intuit, NYC.
We're raising a Series A to scale manufacturing, complete regulatory clearance, and anchor our Gulf operations in Abu Dhabi. We'd welcome a conversation.